This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (47)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Steven R. Bayer, MD; Alan H. DeCherney, MD

JAMA. 1993;269(14):1823-1828.

Abstract
Dysfunctional uterine bleeding is a common gynecologic disorder that can affect any woman during her reproductive years. It is a diagnosis of exclusion, and the clinician must proceed through a logical stepwise evaluation to rule out all other causes of the abnormal bleeding. In most cases dysfunctional uterine bleeding is associated with anovulation. During the pubertal and perimenopausal periods, anovulatory bleeding is a common occurrence. During these transitional states, the abnormal bleeding has a physiological basis and is secondary to an estrogen withdrawal. Anovulatory bleeding can also be associated with chronic anovulation. The chronic unopposed estrogen that characterizes this disorder causes a continuous proliferation of the endometrium; this can result in abnormal bleeding and place the patient at risk for endometrial cancer. The goals of treatment for anovulatory bleeding are to stop the acute bleeding, avert future episodes, and prevent long-term complications. In some cases surgical intervention is indicated, but the foundation of treatment has been a medical approach. Several progestational agents have demonstrated effectiveness and can be administered either orally or by intramuscular injection. If the patient fails to have resolution of the bleeding with medical therapy, another cause of the bleeding must be suspected, and reevaluation is necessary.

(JAMA. 1993;269:1823-1828)

Author Affiliations
From the Department of Obstetrics and Gynecology, New England Memorial Hospital, Stoneham, Mass (Dr Bayer), and the Department of Obstetrics and Gynecology, Tufts University School of Medicine, Boston, Mass (Dr DeCherney).

Footnotes
Reprint requests to the Department of Obstetrics and Gynecology, Tufts University School of Medicine, 750 Washington St, Box 36, Boston, MA 02111 (Dr DeCherney).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Chinese Herbal Medicine for Dysfunctional Uterine Bleeding: a Meta-analysis
Tu et al.
Evid Based Complement Alternat Med 2009;6:99-105.
ABSTRACT | FULL TEXT  

Can we achieve international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding?
Fraser et al.
Hum Reprod 2007;22:635-643.
ABSTRACT | FULL TEXT  

Abnormal Uterine Bleeding: A Management Algorithm
Ely et al.
J Am Board Fam Med 2006;19:590-602.
ABSTRACT | FULL TEXT  

Pesticide Use and Menstrual Cycle Characteristics among Premenopausal Women in the Agricultural Health Study
Farr et al.
Am J Epidemiol 2004;160:1194-1204.
ABSTRACT | FULL TEXT  

A Cost Utility Analysis of Sonograhestrography Compared with Hysteroscopic Evaluation for Dysfunctional Uterine Bleeding
Evans
Journal of Diagnostic Medical Sonography 2000;16:68-72.
ABSTRACT  

A 21-Year-Old Woman With Menstrual Irregularity
Davis
JAMA 1997;277:1308-1314.
ABSTRACT